High Growth Tech Stocks In The US For May 2025
As the U.S. market experiences a notable upswing, with the S&P 500 and Nasdaq Composite marking gains amid strong earnings reports from major tech companies like Microsoft and Meta, investors are keenly observing how these developments impact high-growth tech stocks. In this environment of robust AI spending and positive sentiment, identifying companies with solid financials and innovative strategies becomes crucial for those looking to tap into the potential of high-growth sectors.
Name
Revenue Growth
Earnings Growth
Growth Rating
Super Micro Computer
20.35%
33.99%
★★★★★★
Travere Therapeutics
28.65%
66.06%
★★★★★★
TG Therapeutics
26.06%
37.39%
★★★★★★
Arcutis Biotherapeutics
26.11%
58.46%
★★★★★★
Clene
62.08%
64.01%
★★★★★★
Alnylam Pharmaceuticals
23.08%
58.85%
★★★★★★
AVITA Medical
27.81%
55.17%
★★★★★★
Alkami Technology
20.71%
92.32%
★★★★★★
Ascendis Pharma
32.75%
59.64%
★★★★★★
Lumentum Holdings
21.34%
120.49%
★★★★★★
Click here to see the full list of 236 stocks from our US High Growth Tech and AI Stocks screener.
Let's review some notable picks from our screened stocks.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Ardelyx, Inc. focuses on discovering, developing, and commercializing medicines for unmet medical needs globally, with a market cap of $1.30 billion.
Operations: Ardelyx generates revenue primarily through the development and commercialization of biopharmaceutical products, totaling $333.62 million.
Ardelyx's recent appointment of Dr. Merdad Parsey to its Board underscores a strategic enhancement in governance, potentially enriching its leadership amidst crucial clinical advancements. The company's innovative focus is exemplified by XPHOZAH®, a pioneering treatment for hyperphosphatemia in CKD patients on dialysis, reflecting Ardelyx's commitment to addressing unmet medical needs through novel therapeutic approaches. Financially, Ardelyx has shown significant traction with a revenue jump to $333.62 million from the previous year's $124.46 million, alongside an anticipated transition to profitability within three years, suggesting robust growth prospects driven by both clinical outcomes and market expansion strategies.
Unlock comprehensive insights into our analysis of Ardelyx stock in this health report.
Review our historical performance report to gain insights into Ardelyx's's past performance.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapeutic compounds for diseases with significant unmet needs, with a market cap of approximately $2.41 billion.
Operations: Apellis Pharmaceuticals focuses on developing and commercializing proprietary therapeutics, generating revenue of $781.37 million.
Apellis Pharmaceuticals, set to become profitable within three years, is navigating a transformative phase with strategic board enhancements and significant FDA approvals. Recently, Craig Wheeler joined the board, bringing extensive biopharmaceutical leadership. This governance boost coincides with the FDA's priority review of EMPAVELI for severe kidney diseases—a potential market expander given its $212.53 million Q4 revenue up from $146.38 million last year. With earnings expected to grow 61.29% annually and R&D focused on critical care areas, Apellis is poised for impactful industry contributions amidst forecasts of high return on equity (690.6%) in the near future.
Click to explore a detailed breakdown of our findings in Apellis Pharmaceuticals' health report.
Gain insights into Apellis Pharmaceuticals' past trends and performance with our Past report.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: RingCentral, Inc. offers cloud-based business communications and contact center solutions globally, with a market capitalization of approximately $2.29 billion.
Operations: RingCentral generates revenue primarily from its Internet Software & Services segment, totaling approximately $2.40 billion. The company focuses on providing cloud-based communication and contact center solutions across North America and internationally.
RingCentral's strategic maneuvers in 2025, including the extension of its credit facilities and key partnerships with PCI-PAL and Cox Business, underscore its commitment to expanding its innovative cloud communication solutions. Notably, the company's recent integration with PCI-PAL enhances secure payment capabilities across North America and Europe, a critical feature for maintaining compliance and customer trust in digital transactions. Furthermore, the collaboration with Cox Business is set to transform work experiences by leveraging RingCentral's AI-driven communication platform. These initiatives are pivotal as RingCentral navigates through a competitive landscape marked by a need for high security and seamless customer interactions in cloud communications.
Click here and access our complete health analysis report to understand the dynamics of RingCentral.
Evaluate RingCentral's historical performance by accessing our past performance report.
Unlock our comprehensive list of 236 US High Growth Tech and AI Stocks by clicking here.
Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:ARDX NasdaqGS:APLS and NYSE:RNG.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
31 minutes ago
- Forbes
U.S. Futures Drop As Trump Says He'll Set Unilateral Tariffs In 2 Weeks
U.S. stock futures slumped early on Thursday—with the Dow index dropping by more than 200 points—after President Donald Trump said his administration will soon send letters to other countries unilaterally outlining the tariff rates that will be imposed on them. U.S. President Donald Trump speaks to the media during a guided tour of the John F. Kennedy Center ... More for the Performing Arts. While attending a show at the Kennedy Center on Wednesday evening, Trump was asked about extending the ongoing 90-day tariff pause—which will expire on July 9—and said: 'I would, but I don't think we're going to have that necessity.' The president said the U.S. was negotiating with 15 countries, including Japan and South Korea. Trump then noted that the U.S. has around '150 plus' trading partners and 'at a certain point, we're just going to send letters out…saying this is the deal, you can take it or leave it.' 'We're going to be sending letters out in about a week and a half, two weeks, to countries, telling them what the deal is,' he added. The president touted the proposed agreement with China as a 'great deal,' adding, 'We're very happy with it, we have everything we need.' U.S. stock futures slumped in premarket trading early Thursday, with the benchmark S&P 500 slipping by 0.4% to 6,004 points. The Dow Futures index was the worst hit, dropping by 0.5% to 42,684 points, while the tech-focused Nasdaq Futures fell 0.4% to 21,799 points.
Yahoo
an hour ago
- Yahoo
Will the Stock Market Keep Soaring in 2025? Wall Street Analysts Are Changing Their Forecasts.
The S&P 500 whipsawed from a sharp decline to a rapid rebound in recent months as the economy has remained resilient in the face of tariffs. Wall Street has become incrementally more optimistic about U.S. stocks, and many analysts have raised their year-end forecasts for the S&P 500. Tariffs still represent a threat to stocks as many economists expect recent changes to U.S. trade policy will raise prices and slow economic growth. 10 stocks we like better than S&P 500 Index › The S&P 500 (SNPINDEX: ^GSPC), a benchmark for the broader U.S. stock market, has had one of the most volatile years on record. The index lost more than $6 trillion during the two-day trading period after President Donald Trump announced his "Liberation Day" tariffs as the CBOE Volatility Index (VOLATILITYINDICES: ^VIX) notched its third-largest weekly spike in history. The S&P 500 hit bottom on April 8, closing 19% below the record high it reached less than two months earlier. But the index promptly rebounded when President Trump put a 90-day pause on the reciprocal tariffs he had outlined days earlier, and the index continued to soar as trade tensions with China de-escalated. The S&P 500 soared 6.1% in May, its best performance during the month since advancing 9.2% in May 1990. The index has almost regained its record high and has advanced nearly 3% year to date. That tremendous rally was fueled by the resilient economy and strong corporate financial results. Consequently, many Wall Street analysts have upwardly revised their year-end forecasts for the S&P 500. Here's what investors should know. Analysts have become incrementally more upbeat about U.S. stocks as the recent rally has unfolded. Several have even raised their forecasts concerning the S&P 500. The chart below shows where 17 Wall Street investment banks and research firms think the index will finish the year. It also shows the S&P 500's implied upside (and downside), compared to its current level of 6,040. Wall Street Firm S&P 500 Year-End Target 2025 Implied Upside (Downside) Wells Fargo 7,007 16% Fundstrat 6,600 9% Deutsche Bank 6,550 8% Morgan Stanley 6,500 8% Yardeni Research 6,500 8% UBS 6,400 6% Citigroup 6,300 4% BMO Capital 6,100 1% Goldman Sachs 6,100 1% Barclays 6,050 0% JPMorgan 6,000 (1%) Oppenheimer 5,950 (1%) RBC Capital 5,730 (5%) Bank of America 5,600 (7%) Evercore 5,600 (7%) HSBC 5,600 (7%) Stifel 5,500 (9%) Median 6,100 1% Data source: Yahoo Finance. Year-end targets and implied upside (downside) shown are current as of June 10. The S&P 500 currently has a median year-end target of 6,100 among 17 Wall Street investment banks and research organizations. That implies 1% upside from its current level of 6,040 in the remaining months of 2025. The current consensus reflects an upward revision from May, when the median forecast was 5,900. Goldman Sachs was one of several institutions that recently revised its year-end targets higher. Strategist David Kostin wrote, "We raise our S&P 500 return and earnings forecasts to incorporate lower tariff rates, better economic growth, and less recession risk than was previously expected." Global investors cut their exposure to U.S. stocks by a record amount over the two-month period that ended April 15 as President Trump announced sweeping tariffs, according to Bank of America. The same survey also showed fund managers planned to cut their exposure even further, but that left them on the wrong side of the rally. The rapid rebound in the S&P 500 essentially forced fund managers to allocate more money to U.S. stocks or run the risk of severe underperformance. That trend is ongoing and may continue to push domestic equities higher in the coming weeks. However, investors shouldn't be lulled into a false sense of security. Very real headwinds threaten the U.S. economy. President Trump has effected the most aggressive tariff hike in history. The average tax on U.S. imports in a matter of weeks increased at least 10 percentage points (some analysts estimate 13 percentage points). The last comparable increase occurred in the early 1900s, but tariffs in that situation were imposed over several years and were still followed by a series of recessions. The U.S. economy has so far been resilient despite sweeping changes to U.S. trade policy made by the Trump administration. However, economists still expect tariffs to raise prices and slow economic growth. The International Monetary Fund expects U.S. gross domestic product (GDP) to increase 1.8% this year. That's slower than 2.8% last year and represents a severe downward revision from the pre-tariff projection that called for 2.7% growth. Suffice it to say, the current market environment is uncertain. Investors are on edge as they await negative news about tariffs, yet many continue to put money into stocks for fear of missing the current rally. Keeping a level head is particularly important right now. It never makes sense to pass on the opportunity to buy a high-quality stock at a reasonable price, but chasing stocks that are clearly overvalued is a recipe for disaster. Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and S&P 500 Index wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor's total average return is 996% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Bank of America is an advertising partner of Motley Fool Money. JPMorgan Chase is an advertising partner of Motley Fool Money. Wells Fargo is an advertising partner of Motley Fool Money. Citigroup is an advertising partner of Motley Fool Money. Trevor Jennewine has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bank of America, Goldman Sachs Group, and JPMorgan Chase. The Motley Fool recommends Barclays Plc. The Motley Fool has a disclosure policy. Will the Stock Market Keep Soaring in 2025? Wall Street Analysts Are Changing Their Forecasts. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
PPC Full Year 2025 Earnings: Revenues Beat Expectations, EPS Lags
Revenue: R9.87b (down 1.9% from FY 2024). Net income: R466.0m (up from R16.0m loss in FY 2024). Profit margin: 4.7% (up from net loss in FY 2024). EPS: R0.32 (up from R0.011 loss in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 30%. Looking ahead, revenue is forecast to grow 8.3% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Basic Materials industry in Africa. Performance of the market in South Africa. The company's shares are up 17% from a week ago. You should always think about risks. Case in point, we've spotted 1 warning sign for PPC you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
